ProMetic Life Sciences Inc. Completes Milestone in Tech Transfer to Sinopharm Group

ChinaBio Today -- ProMetic Life Sciences has completed the first milestone in its strategic collaboration with the Wuhan Institute of Biological Products (WIBP), a subsidiary of China National Pharmaceutical Group Corp (Sinopharm). ProMetic has licensed its proprietary protein technologies to Sinopharm, with the goal of allowing WIBP to produce biosimilar drug products. More details...

Back to news